Glutathione S-transferases (GSTs) are a group of phase II detoxification enzymes, which catalyze the conjugation of glutathione (GSH) with carcinogens, among other xenobiotics. The GSTM3 gene is part of the GSTs gene family, and its polymorphism A/B has been associated with risk and protective effects of several cancers. This genetic variant is a deletion of 3 bp (AGG) in intron 6. Previous association studies have performed genotyping using techniques such as polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). In this study, we took advantage of the TaqMan Ò probes features and developed a reliable, faster, more simple and economic method to identify the 3-bp deletion. Our allelic discrimination method was able to distinguish between homozygous A/A, heterozygous A/B and homozygous B/B samples, as shown by TaqMan Ò based real-time PCR. Results were validated by Sanger Sequencing. In conclusion, we developed a specific and rapid method to detect the 3-bp deletion from the GSTM3 A/B polymorphism. Ó 2016 IMSS. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Glutathione S-transferases GSTs are included in the group of phase II detoxification enzymes, which catalyze the conjugation of glutathione (GSH) of a variety of compounds including carcinogens and therapeutic drugs (1) . Several cytosolic and polymorphic families of GST have been identified such as alpha (GSTA), mu (GSTM), omega (GSTO), pi (GSTP), theta (GSTT) and zeta (GSTZ) (2) . In particular, in the GSTM3 gene, two alleles have been described, the wild-type GSTM3 A and the variant GSTM3 B (3) . The latter possess a 3-bp deletion (AGG) in intron 6, which brings origin to a recognition site of the transcription factor Ying Yang (YY1) 5-AAGATA-3 0 (3). Therefore, this deletion could alter the expression of GSTM3, possibly also affecting carcinogen metabolism and cancer susceptibility (4) . Controversial results have been previously reported regarding the association of GSTM3 polymorphisms and the risk or protective effects in different types of cancer and populations. For instance, both GSTM3 A/B and B/B genotypes have been associated with increased risk of laryngeal cancer in Caucasian populations (5) . The same genotypes showed enhanced risk for developing esophageal cancer in a Northern Indian population (4) . Conversely, increased risks of oral cancer and leukoplakia were observed in tobacco smokers with the GSTM3 A/A genotype in an Indian population (6) . Other studies have tested association between GSTM3 A/B polymorphism and breast cancer risk (in a population from northeastern Mexico) (7) and lung cancer susceptibility (in a meta-analysis) (8) . Neither of these showed an association. Because the identification of this polymorphism has been widely performed with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) (3,9e11), we sought to design an alternative, reliable and specific method that allows determination of the deletion in a simpler and faster way. This method will be a very useful tool for those who wish to analyze the GSTM3 A/B polymorphism in future studies.
Material and Methods

Origin of DNA Samples
In order to validate our method, human genomic DNA samples were required. Therefore, experiments were carried out with DNA from 56 healthy volunteers from the Universidad de Monterrey who initially participated in a study to identify obesity-associated biomarkers in the mitochondrial DNA (12) . The study complied with the guidelines of the Declarations of Helsinki and Tokyo and was approved by the Research and Ethics Committee from the Universidad de Monterrey (registration number 322012-ClE). The DNA sample with the homozygous genotype GSTM3 B/B was obtained from a student in the Universidad de Monterrey with Venezuelan ancestry. Informed consent from all participants was obtained.
DNA Extraction
Peripheral blood from the 56 participants was extracted in a tube with EDTA and genomic DNA was isolated with Wizard Genomic DNA Purification Kit (Promega, Madison, WI). Protocol was followed according to manufacturer's instructions. Genomic DNA was quantified by UV absorbance using Nanodrop (Thermo Scientific, Wilmington, DE). The quality of DNA was measured with the A260/280 ratio; a value of 1.8e2 was considered of good quality. All samples were adjusted to a concentration of 10 ng/ml and distributed in a 96-well plate. Samples were kept at À20 C until analysis.
Design of the TaqMan Ò Allelic Discrimination Method
A costumed TaqMan Ò genotyping assay was ordered with Applied Biosystems (Foster City, CA). First, the 3-bp deletion was identified in the GSTM3 gene sequence. The gene sequence was then entered in the File Builder 3.1 software (Applied Biosystems) and the deletion site marked. A file was created and sent to the manufacturer. The allelic discrimination design consisted of oligonucleotides and two labeled probes, which included the wildtype probe labeled with VIC dye (A allele) and the variant probe labeled with FAM dye (B allele, lacking the 3 bp). The passive reference dye included in the assay tube was ROX. Real-time PCR reaction was performed according to the manufacturer's instructions in an ABI PRISM Ò 7000 Sequence Detection System (Applied Biosystems). Briefly, the reaction was set with an input DNA of 20 ng, 1X probe and oligonucleotides mix, 1X TaqMan Ò Universal PCR Master Mix (Applied Biosystems) and nucleasefree water to a total volume of 11 ml. Probes and oligonucleotides sequences are available upon request. Thermal cycling conditions were as following: 60 C for 30 sec, 95 C for 10 min, 40 cycles of: 95 C for 15 sec and 60 C for 1 min. A final post-read method was set at 60 C for 30 sec.
Sequencing Reactions
In order to validate the TaqMan Ò allelic discrimination method, samples were prepared for sequencing. First, end-point PCR was carried out with Go-taq flexi DNA polymerase (Promega) in an Eppendorf Mastercycle EP gradient S Thermal (Eppendorf, Hamburg, Germany). Briefly, 200 ng of DNA were amplified by adding 1X buffer, 1.5 mmol MgCl 2 , 0.2 mmol dNTPs, 0.2 mM of each primer and 1.25 U/reaction DNA polymerase in a total volume of 50 ml. The amplification program included an initial denaturation step of 94 C for 3 min followed by 30 cycles of: denaturation at 94 C for 30 sec, annealing at 56 C for 40 and extension: 72 C for 1 min, a final extension step was set at 72 C for 5 min. Purification of PCR products was performed with QIAquick (Qiagen, Hilden, Germany) following the manufacturer's instructions. Samples were sequenced in a Genetic Analyzer 3100 (Applied Biosystems) by an external supplier, the Instituto Potosino de Investigaci on Cient ıfica y Tecnol ogica (IPICYT, SLP, Mexico). Sequences were analyzed with the CodonCode Aligner software.
Results
TaqMan Ò Allelic Discrimination Method
Samples from the 56 participants were run in the ABI PRISM Ò 7000 Sequence Detection System. The total procedure lasted 3 h, from preparing the PCR reaction to the analysis of the results. Two genotypes were initially identified in these samples (GSTM3 A/A and GSTM3 A/B), with a frequency of 88.33 and 11.67%, respectively. In the 56 samples, no GSTM3 B/B genotype was found. These results were expected becausee frequency of B/B genotype is absent or very low in the northeastern Mexican population (0e4%) (7, 13) .
In order to validate the detection of the homozygous B/B genotype by the TaqMan Ò probe, we sought a DNA sample that possesses this genotype. Homozygous B/B genotype has been found to be more frequent in sub-Saharan African populations (56e58%) and moderately frequent in Caucasians (5e20%) (11) . Therefore, we invited students from the Universidad de Monterrey with foreign ancestry to donate DNA. A total of eight students decided to participate and, surprisingly, one possessed the B/B genotype. Ancestry of this student was documented to be from Venezuela (parents from Venezuela, grandparents from Colombia, Peru and Venezuela, great-grandparents from Italy, Venezuela, Colombia and Peru). TaqMan Ò allelic discrimination was then performed with this sample plus samples previously classified as GSTM3 A/A or GSTM3 A/B and the allelic discrimination plot was observed clearly with three clusters (Figure 1) . Amplification data proved the specificity of the method because fluorescence was detected only for one single allele in homozygous samples and for both alleles in heterozygous samples. Threshold cycle (Ct) values ranged from 26.72 to 29.66. In order to assess the sensitivity of our method, the test was performed with different concentrations of input DNA (15, 10, 5 and 2.5 ng per reaction). Allelic discrimination plot was clearly observed with three clusters for all the diluted samples. Amplification data of the assay carried out with 2.5 ng showed Ct values ranged from 29.0e30.23. These results confirm the high sensitivity of our proposed TaqMan Ò allelic discrimination method.
Validation of the TaqMan Ò Allelic Discrimination Method with Sanger Sequencing
In order to validate the results obtained with the TaqMan Ò allelic discrimination assay, one sample of each phenotype was prepared for sequencing. Sequence analysis showed the absence of the 3 bp in the homozygous B/B sample, the presence of the 3 bp in the homozygous A/A and the combination of both alleles was identified in the sequence of the heterozygous A/B sample (Figure 2 ).
Discussion
In recent years, the features of the TaqMan Ò probes have been considered for the detection of mutations and polymorphisms associated with several diseases such as cancer (14) , dystrophic epidermolysis bullosa (15) , beta thalassemia (16) , among others. In this study, the 3-bp deletion in the GSTM3 gene was identified by our TaqMan Ò allelic discrimination method. The real-time PCR procedure takes an approximate time of 3 h until results are observed in the allelic discrimination plot. The estimated cost of each sample is |$2.5e3 USD. This method is faster, more economic and simpler compared with the regular PCR-RFLP procedure currently used to detect this polymorphism. Results showed high specificity because fluorescence was detected whether for one allele in homozygous samples and for both in heterozygous samples.
The current method most commonly used in the scientific community to detect the GSTM A/B polymorphism is PCR-RFLP, which allows determining the presence or absence of the 3-bp deletion in the GSTM3 gene through the use of conventional end-point PCR and restriction enzymes. Therefore, this technique requires sufficient amount of DNA, 50e100 ng per PCR reaction (10), whereas our TaqMan Ò allelic discrimination method can be carried out only with 2.5 ng. Additionally, the time required to perform PCR-RFLP can be very extensive because various techniques need to be done: PCR for |2 h, digestion that is normally performed overnight or for 18 h (3,10), polyacrylamide gel preparation stained with ethidium bromide and run of the gel for 2 h (3). TaqMan Ò allelic discrimination method allows performing the determination in 2e3 h. Toxicity of polyacrylamide and ethidium bromide, besides the risk of contamination between samples in post-amplification manipulation are some drawbacks of the PCR-RFLP method that are overcome by using Taq-Man Ò probes.
Therefore, this TaqMan Ò allelic discrimination method will allow the development of more GSTM3 association studies in a faster, more specific, sensitive and economic way when comparing to the currently used method (PCR-RFLP).
Conclusion
A new method based on real-time PCR using TaqMan Ò probes has been designed, tested, and proven to be rapid, specific and sensitive for the detection of the GSTM3 A/B polymorphism. 
